Oncolytic viruses as experimental treatments for malignant gliomas: Using a scourge to treat a devil

« Previous Next »Cytokine & Growth Factor Reviews
Volume 21, Issue 2 , Pages 103-117, April 2010

Franz J. Zemp
- Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Southern Alberta Cancer Research Institute, Clark H. Smith Brain Tumor Center, Calgary, Alberta, Canada
Juan Carlos Corredor
- Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Southern Alberta Cancer Research Institute, Clark H. Smith Brain Tumor Center, Calgary, Alberta, Canada
Xueqing Lun
- Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Southern Alberta Cancer Research Institute, Clark H. Smith Brain Tumor Center, Calgary, Alberta, Canada
Daniel A. Muruve
- Department of Medicine, Immunology Research Group, University of Calgary, Calgary, Alberta, Canada
Peter A. Forsyth
- Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Southern Alberta Cancer Research Institute, Clark H. Smith Brain Tumor Center, Calgary, Alberta, Canada
- Corresponding author at: Department of Medicine, Tom Baker Cancer Center, Southern Alberta Cancer Research Institute, 3330 Hospital Drive N.W., Calgary, Alberta, Canada T2N 4N1. Tel.: +1 403 220 6559; fax: +1 403 210 8135.